Sales of antineoplastic agents are expected to be valued at US$ 126.71 billion in 2023, with the market expected to reach a valuation of US$ 286.49 billion by the end of 2033.
The antineoplastic agents market plays a critical role in the global healthcare industry, focusing on the development and distribution of drugs that inhibit the growth and proliferation of malignant cells....
0 Commentarios
0 Acciones
153 Views
0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek